|
2022
|
Invention
|
Motile sperm domain containing protein 2, integrin beta2 and cd63. The present disclosure relates... |
|
|
Invention
|
Treatment methods using adenovirus.
The invention provides methods of reducing or decreasing a s... |
|
2021
|
P/S
|
Scientific and technological services and research and design relating thereto; Industrial analys... |
|
|
Invention
|
Motile sperm domain containing protein 2 antibodies and methods of use thereof. The present discl... |
|
|
P/S
|
Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes;... |
|
|
Invention
|
Oxidized lipids and treatment or prevention of inflammation or infectious disease caused by coron... |
|
2020
|
Invention
|
Methods and compositions for tumor radiosensitization.
Disclosed herein are methods and composit... |
|
|
Invention
|
Methods of anti-tumor therapy.
The disclosure provides methods of treating a tumor in a subject ... |
|
|
Invention
|
Methods of anti-tumor therapy. The disclosure provides methods of treating a tumor in a subject i... |
|
|
Invention
|
Methods of anti-tumor therapy.
The invention provides methods for inducing or improving an anti-... |
|
|
Invention
|
Methods of anti-tumor therapy. The invention provides methods for inducing or improving an anti-t... |
|
2019
|
Invention
|
Methods of inducing responsiveness to anti-angiogenic agent. The invention provides methods of in... |
|
|
Invention
|
Bispecific antibodies to mospd2 and t cell- or nk cell-specific molecules. Disclosed herein are b... |
|
2018
|
Invention
|
Diagnostic methods for anti-angiogenic agent therapy.
The disclosure provides methods of treatin... |
|
|
Invention
|
Diagnostic methods for anti-angiogenic agent therapy. The disclosure provides methods of treating... |
|
|
Invention
|
Oxidized lipids and treatment or prevention of fibrosis. The present invention is directed to met... |
|
|
Invention
|
Formulations and dosage forms of oxidized phospholipids.
The current disclosure provides pharmac... |
|
2017
|
Invention
|
Oxidized lipids and methods of use thereof. The present invention is directed to oxidized lipids ... |
|
|
Invention
|
Method and composition to increase radiation-induced tumor therapeutic effects.
Disclosed herein... |
|
|
P/S
|
Providing medical and scientific research information in the field of pharmaceuticals and clinica... |
|
|
Invention
|
High-purity phospholipids. Novel synthetic routes, which are highly applicable for industrial pre... |
|
2016
|
Invention
|
Motile sperm domain containing protein 2 and cancer. Disclosed herein are methods of treating, re... |
|
|
Invention
|
Motile sperm domain containing protein 2 and inflammation. Disclosed herein are methods of treati... |
|
2015
|
Invention
|
Oxidized lipids. The present invention is directed to oxidized lipids and pharmaceutical composit... |
|
|
Invention
|
Combined treatment utilizing vb-201.
Methods of treatment which utilize co-administration of the... |
|
2014
|
Invention
|
Fas-chimera adenovirus vector. The invention provides methods of reducing or decreasing a size of... |
|
|
Invention
|
Endothelial cell-specific polynucleotides and use thereof. An isolated polynucleotide is disclose... |
|
2013
|
Invention
|
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of ang... |
|
|
Invention
|
Treatment methods using adenovirus. The invention provides methods of reducing or decreasing a si... |
|
|
Invention
|
Compositions and methods for treating glioblastoma gbm. Methods of treating a malignant glioma in... |
|
|
Invention
|
Methods of producing adenovirus vectors and viral preparations generated thereby.
The present in... |
|
|
Invention
|
Oxidized lipid compounds and uses thereof.
Novel oxidized lipids are provided herein, as well as... |
|
|
Invention
|
Promoters exhibiting endothelial cell specificity and methods of using same. An isolated polynucl... |
|
|
Invention
|
Methods for use of a specific anti-angiogenic adenoviral agent.
Anti-angiogenic adenovirus vecto... |
|
|
Invention
|
Formulations and dosage forms of oxidized phospholipids. The current disclosure provides pharmace... |
|
|
Invention
|
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations o... |
|
|
Invention
|
Methods for treating psoriasis and vascular inflammation.
Described are methods of decreasing va... |
|
|
Invention
|
Methods for treating psoriasis and vascular inflammation. Described are methods of decreasing vas... |
|
2012
|
Invention
|
Treatment of inflammation.
Disclosed herein are methods of treating an inflammatory disease or d... |
|
2011
|
Invention
|
Methods for use of a specific anti-angiogenic adenoviral agent. Anti-angiogenic adenovirus vector... |
|
|
Invention
|
Compositions and methods for treating glioblastoma gbm.
Methods of treating a malignant glioma i... |
|
2010
|
P/S
|
Development of new treatments for pathologies in which vascular biology plays a critical role in ... |
|
2009
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
2008
|
P/S
|
Viral or non-viral vectors to be used in gene delivery, gene transfer, gene regulation and gene m... |
|
|
P/S
|
development of new treatments for pathologies in which vascular biology plays a critical role in ... |
